Metraipolis › archive › dc_583b73f2fcdc

Heterologous prime-pull mucosal vaccination with an adjuvanted RBD vaccine elicits robust IgA production and protects against SARS-CoV-2 — Europe PMC PMID:41050681

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41050681
DOI: 10.3389/fimmu.2025.1673460
License (as archived): solo-consultazione
Archived: 2026-11-09T20:41:35.470Z
SHA-256 of the archived text: 693b86db0bcb4c32dff5d95fec575cf0b8f3180628a5139d817187cb80188caa
Stable URL of this page: https://metraipolis.com/documento/dc_583b73f2fcdc

How to cite

Heterologous prime-pull mucosal vaccination with an adjuvanted RBD vaccine elicits robust IgA production and protects against SARS-CoV-2 — Europe PMC PMID:41050681 — Europe PMC (en), https://europepmc.org/article/MED/41050681 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_583b73f2fcdc (Metraipolis archive dc_583b73f2fcdc, sha256 693b86db0bcb4c32dff5d95fec575cf0b8f3180628a5139d817187cb80188caa)

BibTeX

@misc{dc583b73f2fcdc,
  title = {Heterologous prime-pull mucosal vaccination with an adjuvanted RBD vaccine elicits robust IgA production and protects against SARS-CoV-2 — Europe PMC PMID:41050681},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41050681},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_583b73f2fcdc; sha256 693b86db0bcb4c32dff5d95fec575cf0b8f3180628a5139d817187cb80188caa},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41050681. Agents can read the archived copy with the MCP tool read_document.